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1  | INTRODUC TION
Atopic	dermatitis	 (AD)	 is	a	chronic,	 relapsing	skin	disease	with	a	
prevalence	of	10%‐20%	 in	West‐European	children.1	AD	 is	 char‐
acterized	by	immunological	changes,	skin	barrier	dysfunction	and	
changes	 in	 the	microbial	 composition	 of	 the	 skin,	 influenced	 by	




























biome.	 A	 study	 performed	 in	 healthy	 individuals	 within	 different	
humidity	and	temperature	conditions	showed	an	effect	on	the	quan‐
tities	of	bacteria	on	the	skin.18	Furthermore,	UV‐R	can	modulate	the	
skin	microbiome	 by	 causing	 direct	microbial	DNA	 damage	 and	 by	
affecting	the	immune	system.19‐22
Evaluation	of	alpine	climate	treatment	has	mainly	focused	on	the	
immune	 system.	 The	 effect	 of	 alpine	 climate	 on	 the	 skin	microbi‐











cluding	 children	 with	 difficult	 to	 treat	 AD.	 The	 trial	 is	 registered	
at	 Current	 Controlled	 Trials	 (ISRCTN88136485).	 The	 detailed	
study	 protocol	 and	 primary	 outcomes	 have	 been	 published	 previ‐
ously.14,23	Briefly,	Dutch	children	and	adolescents	were	randomized	
to	a	six‐week	personalized	integrative	multidisciplinary	(PIM)	treat‐
ment	 in	either	a	 clinic	 in	 the	Swiss	alps	at	1560	metres	 (interven‐













to	 step	down,	 or	 current	 use	of	 systemic	 immunosuppressive	 treat‐











skin.	 Samples	 taken	 from	 the	 lesional	 skin	 were	 preferably	 taken	
from	 the	 antecubital	 fold	 or	 the	 popliteal	 fold.	 Non‐lesional	 skin	
samples	were	taken	from	the	volar	arm	if	possible.	We	used	sterile	
cotton	 swabs	 soaked	 in	 sterile	NaCl	0.9%.	Skin	 samples	were	col‐
lected	by	rubbing	the	skin	for	30	seconds.	All	samples	were	stored	at	
−80ᵒC	until	further	processing.
2.4 | DNA isolation and qPCR
For	 DNA	 isolation,	 phenol	 extraction	 and	 magnetic	 beads	 were	
used	(Agowa	mag	Mini	DNA	isolation	kit;	LCG).	First,	150	uL	from	
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GTC	ACT	CTG	T)	and	the	16S‐S.epi	MGB	Taqman	probe	(CCT	CTG	













were	 bidirectionally	 sequenced	 using	 the	 MiSeq	 system.24	 Samples	









Our	 statistical	 analysis	 was	 performed	 in	 patients	 with	 available	
data	 at	 both	 time‐points	 per	 outcome.	 Shannon	 diversity	 index	
was	 calculated	 at	 genus	 level	 on	 non‐subsampled	 unfiltered	 data.	
For	 further	 analysis	 of	 the	microbiome,	we	 used	 non‐subsampled	
genus	tables	and	excluded	genera	with	a	relative	abundance	lower	
than	0.0001.	Prior	 to	ordination	analysis,	 the	filtered	genus	tables	
were	 square‐root	 transformed	 with	 subsequent	 application	 of	
Wisconsin	double	standardization.	To	visualize	bacterial	community	
compositions,	Bray‐Curtis	distance‐based	multidimensional	 scaling	
(MDS)	 was	 used.	 Permutational	 multivariable	 analysis	 of	 variance	
(PERMANOVA)	was	used	to	determine	significant	changes	in	micro‐
biota.	To	assess	whether	the	change	in	microbiota	was	significantly	
different	between	both	 treatment	groups,	we	used	 the	 covariates	
“time‐point”	 (T0	 or	 T1)	 and	 “treatment	 group”	 (alpine	 climate	 or	
moderate	 maritime	 climate)	 as	 interaction	 terms	 in	 this	 model.	 If	
any	 statistically	 significant	 difference	 was	 detected,	 we	 obtained	
PERMANOVA	coefficients	 to	determine	which	genera	contributed	
most	to	this	change.26
To	 detect	 changes	 in	 relative	 abundance	 within	 the	 10	 most	
abundant	genera	over	time,	we	performed	univariate	analysis	using	a	
negative	binomial	generalized	linear	model.27	In‐depth	analysis	was	
performed	on	S aureus and S epidermidis	 abundance	by	comparing	
log10	transformed	concentrations	(fg/uL).	Undetectable	DNA	con‐
centrations	were	 noted	 as	 equal	 to	 zero	 and	 referred	 to	 as	 nega‐
tive.	A	 linear	mixed‐effect	model	with	post	hoc	analysis	was	used	
to	assess	the	changes	in	S aureus and S epidermidis.	The	differences	
between	 both	 treatment	 groups	were	 assessed	 by	 calculating	 the	
interaction	 between	 covariates	 “time‐point:treatment	 group”.	 This	
statistical	model	was	also	applied	to	Shannon	diversity	index.
Statistical	 analysis	 was	 performed	 in	 SPSS	 (version	 21)	 and	 R	
software	(version	3.5.1).	linear	mixed‐effect	models	were	performed	
using	 “lme”	 and	 “lme4”	package.	Post	hoc	 analysis	was	performed	
with	“multcomp”	package	and	corrected	for	multiple	testing.28,29	We	
used	 the	packages	 “ape”	and	 “vegan”	 for	MDS	and	PERMANOVA,	
respectively.30	 In	this	model,	we	accounted	for	repeated	measure‐



























All	 sequences	belonged	 to	603	genera.	After	 filtering,	213	genera	
remained.	The	10	most	abundant	genera	on	lesional	and	non‐lesional	
skin,	before	and	after	both	treatment	regimens,	are	shown	in	Figure	
S2.	Staphylococcus	was	 predominant	 in	 all	 groups	 followed	by	 the	
Corynebacterium	genus	and	Streptococcus	genus.
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composition	 did	 not	 differ	 significantly	 between	 both	 treatment	
groups	(PERMANOVA:	lesional	skin:	R2	=	.025,	P	=	.25,	non‐lesional	











Compared	 with	 baseline,	 Shannon	 diversity	 index	 was	 signifi‐
cantly	increased	after	alpine	climate	treatment	on	both	lesional	and	
non‐lesional	skin	 (P < .01 and P	=	 .02	respectively).	This	could	not	
be	observed	after	moderate	maritime	climate	(P = .26 and P	=	 .70,	
respectively).	Moreover,	the	change	in	Shannon	index	was	not	sig‐
nificantly	 different	 between	 both	 treatment	 groups	 (lesional	 skin	
P	=	.26	and	non‐lesional	skin	P	=	.07;	Figure	3).
3.4 | Effect of alpine climate treatment on the 







3.5 | Effect of alpine climate treatment on species 
within the Staphylococcus genus
To	get	more	insight	in	the	Staphylococcus	genus,	additional	qPCR	was	










6	weeks	of	treatment,	the	decrease	 in	S aureus	 load	on	 lesional	skin	

















biome	 on	 both	 lesional	 and	 non‐lesional	 skin	 in	 children	with	 dif‐
ficult	to	treat	AD.	We	found	a	significant	change	in	the	overall	skin	




F I G U R E  1   Flowchart of study participants
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index,	Staphylococcus abundance and S aureus	load	in	particular.	The	
reduction	 in	S aureus	 load	was	significantly	 larger	when	compared	




ment	 on	 the	 skin	microbiome	 in	 patients	with	 AD.	 Alpine	 climate	
offers	 favourable	 features	 for	 patients	 with	 AD,	 including	 lower	
exposure	 to	 allergens	 and	 pollution	 and	 an	 increased	 UV‐R.11,12 
Moreover,	 children	 treated	 in	 alpine	 climate	were	 separated	 from	





posed	 that	geographical	variability,	with	variation	 in	UV‐R,	can	 in‐
fluence	the	skin	barrier	and	the	microbiome.2,33	Although	this	study	










population,	 a	 significantly	 larger	 decrease	 in	 disease	 severity	was	
observed	following	alpine	climate	treatment	than	maritime	climate	
TA B L E  1  Baseline	characteristics
 










































F I G U R E  2   Bray‐Curtis distance‐based multi‐dimensional scaling 
plot showing the microbiota of the lesional skin samples before and 
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treatment	(P	<	.01).	The	SA‐EASI	score	decreased	from	a	median	of	
39.0	 (IQR	18.7‐59.3)	 to	2.6	 (IQR	0.3‐6.2)	and	40.8	 (IQR	22.2‐52.8)	
to	 12.0	 (IQR	 3.6‐22.1)	 after	 six‐week	 treatment	 in	 alpine	 climate	
and	moderate	maritime	 climate,	 respectively.14	 Literature	 shows	 a	









However,	 the	 changes	 in	 Shannon	 diversity	 index,	 Staphylococcus 










nation	can	be	 the	higher	diversity	and	 lower	Staphylococcus abun‐






were	 dominated	 by	 the	 Staphylococcus	 genus.	 These	 results	 sup‐
port	previous	literature	describing	an	excess	of	Staphylococcus, and 
more	 specific	of	S aureus,	 in	 the	 skin	microbiome	of	patients	with	
AD.3,7,36	Other	abundant	genera	 included	Streptococcus	 (known	 to	
























We	did	not	find	a	significant	change	in	S epidermidis load in our 
study.	The	role	of	S epidermidis	in	the	pathogenesis	of	AD	is	still	un‐
clear	 and	 literature	 on	 this	 subject	 is	 conflicting.7,40,41	Due	 to	 the	
inhibitory	effect	of	S epidermidis on S aureus,	by	the	production	of	
bacteriocins,	serine	protease	Esp	and	phenol‐soluble	modulins,	some	
correlation	may	be	expected.42‐44	In	a	previous	study,	an	increase	in	
S epidermidis	was	 found	during	disease	 flare	 in	patients	with	AD.7 








mate,	 was	 the	 supervision	 leading	 to	 optimal	 treatment	 compli‐
ance.	It	might	be	that	due	to	supervision,	the	application	of	topical	
corticosteroids	was	more	 adequately	 and	 frequent	 in	 this	 group	
and	could	have	affected	disease	severity	and	the	skin	microbiome.	




group	of	patients	with	difficult	 to	 treat,	moderate	 to	severe	dis‐
ease.8,45	 During	 this	 study,	 the	 use	 of	 medication	 was	 carefully	
monitored	 and	 showed	 no	 significant	 differences	 between	 both	
treatment	groups.	Results	for	patients	using	systemic	medication	
at	T0	did	not	deviate	from	the	rest	of	the	study	population	(data	
not	 shown).	 Moreover,	 the	 proportion	 of	 patients	 using	 topical	
and/or	 systemic	 medication	 during	 the	 intervention	 was	 stable	
(Table	S2).
A	limitation	of	this	study	was	the	use	of	the	V4	hypervariable	
region	 for	 sequencing.	 With	 this	 variable	 region	 it	 is	 not	 pos‐
sible	 to	 properly	 detect	 the	 Propionibacterium	 or	 to	 classify	 the	
Staphylococci	 at	 species	 level.	 To	overcome	 this	 problem	 for	 the	





This	 study	 encourages	 to	 perform	 explanatory	 studies	 with	 a	
similar	 treatment	 setting	 in	 both	 climates	 to	 confirm	 the	 effect	 of	
climate	conditions	alone	on	 the	 skin	microbiome.	 Including	 samples	
from	the	skin	of	healthy	subjects	in	future	studies	might	give	us	more	
F I G U R E  4   Quantitative PCR results of the lesional skin samples for Staphylococcus aureus and S epidermidis before and after the six‐week 
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information	about	the	differences	in	the	skin	microbiome	between	AD	
and	controls	and	assess	 if	a	decrease	in	disease	severity	(which	was	






nificant	 change	 in	 the	microbiota	 on	 lesional	 skin.	 In	 addition,	we	
found	a	significant	increase	in	Shannon	diversity	index	and	a	signif‐
icant	decrease	in	abundance	of	the	Staphylococcus	genus	and	S au‐
reus	 load	on	both	 lesional	and	non‐lesional	 skin.	This	 study	shows	








for	enabling	patients	 to	participate	 in	our	study	by	 referring	 them	
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